Introduction
The type I insulin-like growth factor receptor (IGF-IR) is a multifunctional tyrosine kinase receptor that regulates cellular growth in at least four dierent ways: (i) it is mitogenic (Baserga, 1994; Reiss et al., 1998b) ; (ii) it protects normal and tumor cells from apoptosis (Gluckman et al., 1992; Sell et al., 1995) ; (iii) in certain circumstances it may control neuronal dierentiation ; and (iv) it plays an important role in transformation by several viral and cellular oncogenes, and in the maintenance of the transformed phenotype (Baserga, 1995; Baserga et al., 1997) . The requirement for a functional IGF-IR in malignant transformation has been demonstrated by the use of R 7 cells, which are 3T3-like cells isolated from mouse embryos with a targeted disruption of the IGF-IR genes Liu et al., 1993) . Without IGF-IR, R 7 cells cannot be transformed by a number of genetic manipulations that easily transform the parental 3T3 cells. These include SV40 T antigen, activated Ha-ras oncogene (Sell et al., 1993 , bovine papilloma virus E5 protein (Morrione et al., 1995) , human papilloma virus (Steller et al., 1996) , activated c-src , and overexpressed growth factor receptors, including EGF , PDGF (DeAngelis et al., 1995) and insulin (Miura et al., 1995) receptors. In agreement with these ®ndings, antibodies against the IGF-IR (Kalebic et al., 1994) , antisense expression plasmids (Trojan et al., 1992 (Trojan et al., , 1993 Resnico et al., 1994; Shapiro et al., 1994) , and dominant negative mutants of the IGF-IR (Prager et al., 1994; Burgaud et al., 1995; Reiss et al., 1998a Reiss et al., , 1999 can attenuate malignant tumor growth by inducing apoptosis, and/or by inhibiting cell proliferation.
In the central nervous system (CNS), IGF-IR has been implicated in fetal and postnatal growth and development of the brain (LeRoith et al., 1993) as well as in brain tumors. The presence of an active IGF system has been shown in astrocytomas (Antoniades et al., 1992) , glioblastomas (Trojan et al., 1992 (Trojan et al., , 1993 Resnico et al., 1994) , meningiomas (Antoniades et al., 1992) , and neuroblastoma cells (Martin et al., 1992) .
Little is known about the role of the IGF-IR system during development and progression of medulloblastomas, which represent about 25% of all pediatric brain tumors. Recently, Patti et al. (2000) have found that an autocrine IGF-I loop activates proliferation of the Daoy human medulloblastoma cell line, suggesting that the IGF-IR system may be involved in the development and/or progression of these cerebellar tumors. To address this issue in more detail we propose to: (i) characterize the IGF-IR system in a new transgenic mouse model of medulloblastoma; (ii) determine whether any of the IGF-IR signaling components are altered in mouse and human medulloblastomas in comparison with developmentally matched normal cerebellar tissue; and ®nally (iii) correlate activity of the IGF-IR in medulloblastoma cell lines in vitro with IGF-IR phosphorylation in medulloblastoma biopsies.
We have found that medulloblastoma biopsies demonstrated cells with the phosphorylated (active) form of the IGF-IR, as shown by anti-pY1316 antibody staining (Rubini et al., 1999) . Additionally, we examined four mouse BsB8, BsB13) and three human (Daoy, TE-671, D283 Med) medulloblastoma cell lines that are all positive for neuronal markers such as synaptophysin, class III b-tubulin and neuro®lament proteins, and are negative for glial ®brilliary acidic protein (GFAP). The cell lines selected possess the major components of the IGF-IR system, and grossly overexpress IRS-1. They responded with proliferation when stimulated solely with IGF-I, and were strongly inhibited when challenged with either a dominant negative mutant of the IGF-IR or antisense oligonucleotides against IGF-IR mRNA. Importantly, the mouse medulloblastoma cell lines characterized in this study can be utilized in a syngenic animal model to study the ecacy of anti-IGF-IR strategies directed against medulloblastoma cells in vivo.
Results

Activity of the IGF-IR system in biopsies from patients with medulloblastoma
Recently an antibody against the phosphorylated (active) form of the IGF-IR has been developed and characterized by Rubini et al. (1999) . This antibody speci®cally recognizes phosphotyrosine 1316 (pY1316) of the b subunit of IGF-IR, and does not cross-react with the corresponding moiety of the activated insulin receptor (Rubini et al., 1999) . To determine whether IGF-IR is activated in human medulloblastomas in vivo, paran sections of medulloblastoma biopsies were stained with the anti-pY1316 antibody. Figure  1c (low magni®cation) and Figure 1e (high magni®ca-tion) shows groups of tumor cells in a representative biopsy, which were strongly positive for anti-pY1316 by immunohistochemistry. A facing section was probed with an antibody that recognizes total IGF-IR ( Figure  1d ,f) and cells within this section were uniformly stained. A section of normal human cerebellum, used here as a reference tissue, was completely negative for the anti-pY1316 antibody staining ( Figure 1a ) and weakly positive for the total IGF-IR immuno-staining ( Figure 1c ). Note that in normal human cerebellum Purkinje cells were apparently positive for the total IGF-IR immuno-staining, cells from granular layer were weakly positive, and cells from the molecular layer were negative (Figure 1b) . These results suggest that while the IGF-IR protein is present in the majority of tumor cells, the phosphorylated form of the IGF-IR is not omnipresent since it was detected only in certain areas within the tumor and only some of these cells showed strong anti-pY1316 reactivity (compare Figure 1c and d) . Table 1 gives the description of medulloblastoma biopsies examined in this study. Six cases including one classic and ®ve desmoplastic medulloblastomas were characterized in respect to: gender and age of the patient; location of the tumor; presence (+) or absence (7) of conventional neuronal (SY-38 and NF) and glial (GFAP) markers; and ®nally presence (+) or absence (7) of anti-IGF-IR and anti-pY1316 antibody staining. Cells in all six medulloblastoma cases examined were positive for the IGF-IR, which showed uniform staining across the sections (see also Figure 1d ). The anti-pY1316 antibody staining, although also present in all six biopsies examined, was not as uniform as detected for total IGF-IR antibody staining, showing areas within the tumor tissue where groups of cells were strongly positive. It has to be emphasized however, that some areas within the positive section were completely negative for the anti-pY1316 antibody staining, implying the presence of a local auto-and/or para-ctine IGF system in these tumors. Estimated percentage of cells positive for the anti-pY1316 antibody staining is given in parentheses (Table 1) .
Detection of activated IGF-IR in medulloblastoma cell lines
As demonstrated in Figure 1 human medulloblastomas showed reactivity with anti-pY1316 antibody, suggesting continuous activation of the IGF-IR in these tumors. This antibody was also utilized in vitro to further characterize its speci®city and to analyse phosphorylation of the IGF-IR in medulloblastoma cell lines following IGF-I stimulation. Figure 2 shows that the immuno-reactivity is associated with IGF-I stimulation. Mouse and human medulloblastoma cell lines were cultured in serum-free medium for 48 h and the quiescent cells were subsequently stimulated with IGF-I (50 ng/ml) for 15 min (Figure 2a, c, e, g, i, k) , or were left without stimulation (Figure 2b, d, f, h, j, l) . All cell lines stimulated with IGF-I were characterized by strong granular staining. In contrast, quiescent mouse Bs-1b, Bs-1c, BsB8 cells (Figure 2b ,d,f) and human D283 Med cells (Figure 2j) , tested with the antipY1316 antibody showed much weaker diuse staining, similar to the background staining obtained when the primary antibody was omitted from the reaction (Figure 2i picture B) . These results indicate that anti- (Krynska et al., 1999) .
Levels of IGF-IR, IRS-1, and PI3-K in medulloblastoma cell lines
Proceeding from the ®nding that IGF-IR is activated in medulloblastoma tissues and cell lines, we looked for potential abnormalities within the IGF-IR system. Normal cerebellar tissues isolated from mice agematched to those from which the medulloblastoma cell lines originated, were utilized as reference samples. Thick frozen sections of normal human cerebellum collected from autopsies of 11 weeks (N906), 26 weeks (N1061) children, and 36 years old (N989) individuals, were used as reference samples for the human medulloblastoma cell lines. As shown in Figure 3a, (Reiss et al., 1998b; Rubini et al., 1997) , and have been repeatedly used in semiquantitative assays of IGF-IR levels in cells and tissues (Reiss et al., 1998a (Reiss et al., ,b, 1999 . Levels of the IGF-IR in mouse medulloblastoma cell lines were only slightly altered when compared with control mouse cerebellar tissue. We subsequently examined PI3-K that links IGF-IR signaling with the Akt/PKB activation ± pathway/s associated with cell protection from apoptotic death (Kulik et al., 1997; Kaumann-Zeh et al., 1997) . As shown in Figure 3 only small dierences were found for PI3-K protein levels when the medulloblastoma cell lines were compared with control mouse (Figure 3a ) or human cerebellum ( Figure 3b ). In contrast to IGF-IR and PI3-K, the major IGF-IR substrate, IRS-1 was signi®cantly increased in medulloblastoma cell lines (Figure 3a, b) . Densitometric analysis showed that the mouse medulloblastoma cell lines, Bs-1b, Bs-1c, BsB8 and BsB13 have about fourfold; ®vefold; 10-fold and 12-fold higher IRS-1 protein levels respectively, when compared with normal mouse cerebellum. Additionally, levels of IRS-1 in medulloblastoma cell lines were comparable to those found in mouse R600 ®broblasts that have previously been shown to express high levels of IRS-1 . Overall levels of the IGF-IR and IRS-1 proteins in mouse medulloblastoma cell lines ( Figure  3a ) were similar to those detected in human medulloblastoma cell lines (Figure 3b ) with the exception of Daoy cells, where both IGF-IR and IRS-1 were found to be present at considerably lower levels. The major dierence between mouse and human cells is related to the fact that the IGF-IR and IRS-1 proteins levels were very low (not detectable with the exposure time shown in Figure 3b ) in the three control specimens (N906, N989, N1061) of human cerebellum. This comparison between control tissues and tumor cell lines point to an apparent reactivation of both IGF-IR and IRS-1 expression in human medulloblastoma cell lines, and to strong activation of IRS-1 in mouse medulloblastoma cell lines. Importantly, when the same blots were re-probed with anti-PI3-K antibody, an apparent 85 kD band was detected in all protein samples, including human cerebellar tissues. To con®rm good preservation of cellular proteins in frozen human samples, the blots were additionally probed with antiShc, anti-EGF-IR, and anti-Grb-2 antibodies respectively ( Figure 3c ).
IGF-IR signaling in medulloblastoma cell lines
The immunocytochemical data depicted in Figures 1 and 2 demonstrate the initial activation steps of the IGF-IR system, i.e., autophosphorylation of the bsubunit of IGF-IR. By immuno-precipitating the IGF-IR and probing corresponding blots with the antiphospho-tyrosine antibody, we were able to con®rm IGF-IR phosphorylation in selected medulloblastoma cell lines (Figure 4a ). Only cells stimulated with the IGF-I (+) had an apparent 97 kD (IGF-IRb) band. Interestingly, TE-671 cells have an additional strong band at the level of about 80 ± 85 kD that is tyrosine phosphorylated and co-precipitates with the IGF-IR independently from the IGF-I stimulation. Loading conditions were monitored by re-probing the same blots with the antibody directed against the b subunit of IGF-IR (lower part of Figure 4a ).
Activated IGF-IR recruits and phosphorylates its major substrate, IRS-1. Figure 4b shows that selected mouse and human medulloblastoma cell lines phosphorylated IRS-1 on tyrosine residues within 15 min after IGF-I stimulation. Forty-eight hours following serum starvation IRS-1 tyrosine phosphorylation was not detectable in Bs-1b, BsB8 and Daoy cells. In contrast, serum starved TE-671 cells possessed detectable levels of the tyrosine phosphorylated IRS-1, suggesting the possibility of an autocrine activation in these human cells. The lower part of Figure 4b shows loading conditions in this experiment.
Activated IGF-IR leads to the activation of Ras/ MAP kinase pathway via SHC proteins or partially by recruiting IRS-1 (Myers et al., 1993; Waters et al., 1993) . Although this is a routine procedure, we have examined Erk1/Erk2 phosphorylation following IGF-I treatment (Figure 4c) . In all medulloblastoma cell lines examined, short term IGF-I stimulation resulted in Erk1/Erk2 phosphorylation on threonine 202 and tyrosine 204, the event that triggers their kinase activity (Payne et al., 1991) . In contrast to residual phosphorylation of the IRS-1 detected in TE-671 cells cultured in serum-free medium (Figure 4b ), MAP kinases were not activated without additional stimulation, suggesting that exogenous IGF-I is still required to activate MAP kinases in this experimental setting. To monitor To determine good preservation of the human samples blots from (b) were`stripped' and re-probed with anti-Shc, anti-EGF-R and anti-Grb-2 antibodies. Only ®rst four lanes are shown including protein extract from R600 cells as a positive control loading conditions, the same blots were re-probed with the antibody that recognizes Erk1 and Erk2 independent of their phosphorylation status, (lower part of Figure 4c ).
The Western blot depicted in Figure 4d is the same one shown in Figure 4c after re-probing with the antiphospho-Akt antibody. This was done to monitor Akt phosphorylation in the same experimental samples as described for MAP kinases. Samples that had demonstrated activated MAP kinases following IGF-I stimulation were also characterized by an apparent Akt/PKB phosphorylation (Figure 4d) . A clear abnormality in Akt activation was detected in TE-671 cells. In contrast to all other cell lines, serum starved TE-671 was able to keep Akt phosphorylated, even when the process of serum starvation was prolonged up to 72 h (not shown).
IGF-I-dependent growth and survival of medulloblastoma cell lines
Our results (Figure 3) suggest that the IGF-IR and IRS-1 proteins detected in mouse and human medulloblastoma cell lines are expressed at levels (Reiss et al., 1998b; Rubini et al., 1997) that ought to support cell proliferation and survival. In fact, Figure 5 shows that medulloblastoma cell lines are indeed able to proliferate when stimulated solely with IGF-I. Cell proliferation was evaluated by determining cell number prior to stimulation (T0), and at two dierent time points following IGF-I stimulation, as described in our previous papers (Reiss et al., 1998b; Morrione et al., 2000) . All cell lines examined also showed restricted abilities to increase cell number when cultured in serum-free medium without stimulation. However, these responses were marginal when compared with the magnitude of cell proliferation in the presence of IGF-I. There was again one exception, TE-671 human cells proliferated in serum-free medium almost as eciently as in the presence of IGF-I ( Figure 5 ). In all other cell lines an average of about threefold increase in cell number was observed over a period of 4 days following IGF-I stimulation ( Figure 5 ).
When JCV T-antigen positive (BsB8, BsB13) and negative (Bs-1b, Bs-1c) mouse cell lines were analysed in monolayer cultures their growth responses to IGF-I stimulation ( Figure 5 ), or to serum stimulation (not shown) were similar. Dierences began to emerge when the cells were analysed in anchorage-independent conditions. To deny attachment, cells were cultured on 35 mm dishes covered with polyHema as previously described (Reiss et al., 1998b; Valentinis et al., 1999a) . In suspension, T-positive cell lines (BsB8 and BsB13) survive well in serum-free medium (Figure 6a ). In contrast, T-negative cell lines (Bs-1b and Bs-1c) die in suspension when cultured in serum-free medium, showing 57% decrease and 32% decrease in cell number respectively. The cell loss was completely prevented by the IGF-I (Figure 6a ), or partially attenuated by the presence of 10% FBS (Figure 6b compare open bars). The T-positive cells BsB8 and BsB13 responded to IGF-I treatment with cell proliferation showing 227 and 128% increases in cell number respectively. On the other hand, T-negative Bs1b and Bs-1c cells grew much slower showing only 8% increase and 31% increase in cell number when stimulated solely with the IGF-I (Figure 6a) .
The next set of experiments analysed the degree to which impairments of IGF-IR function aect growth and survival of medulloblastoma cell lines in culture. These experiments were also conducted in anchorageindependent conditions, i.e. when cells are denied attachment to the extracellular matrix. Figure 6b shows the results from one human and two mouse medulloblastoma cell lines. The cells were plated in (Figure 6b, open bars) . Subsequently, cell growth and survival were analysed following challenge with antisense oligonucleotides against the IGF-IR mRNA (AS), or after treatment with the conditioned medium containing a dominant negative mutant of the IGF-IR (486/CM) (Reiss et al., 1998a) . As illustrated in Figure 6b all cell lines responded strongly to the treatments. In comparison to the cell number determined before the treatment (T0), the number of Bs-1b cells decreased by 69 and 79% following AS treatment or 486/CM treatment respectively. The number of Bs-B8 cells was reduced by 66% following AS treatment and by 36% in the presence of 486/CM. Finally, cell loss observed in TE-671 was 24% for AS treatment, and 43% for 486/CM treatment. Importantly, cells in control conditions treated either with equal concentrations of the mismatched oligonucleotides (MM), or with control-conditioned medium (C/CM) (see Material and methods), were much less aected. When the Bs1b cells were treated with MM oligonucleotides or with C/CM, 24 and 27% decreases in cell number were observed respectively. BsB8 cells cultured in the presence of MM or C/CM were still able to proliferate, showing a 51 and 73% increase in cell number. The same was observed for TE-671 cells that showed a 73% increase in cell number after the treatment with MM oligonucleotides, and a 74% increase following C/CM treatment. The inset in Figure 6b shows the speci®city and eciency of the antisense treatment. When compared with untreated cultures (lane 5), BsB8 cells treated with AS showed dose and time dependent downregulation of the IGF-IR protein. IGF-IR was barely detectable by Western blotting when BsB8 cells were exposed to 150 nM AS for 36 h (Figure 6b , lane 4).
Discussion
The ®nding that the phosphorylated form of the IGF-IR is present in medulloblastoma biopsies (Figure 1 ) emphasizes the potential involvement of the IGF-IR system in the development and progression of these tumors. These results clearly indicate that the IGF-IR system is not only functional in vitro when cells are stimulated with IGF-I (Patti et al., 2000) , but is also continuously active in several medulloblastomas examined in this study.
We have selected three human and four mouse medulloblastoma cell lines to explore further the involvement of IGF-IR in the growth of medulloblastomas. Our ®ndings can be summarized as follows: (i) mouse and human medulloblastoma cell lines all express functional IGF-IR that is tyrosine phosphory- IGF-IR molecules per cell which were not signi®cantly dierent from those found in control mouse and human cerebellum; (iii) PI3-K, one of the IGF-IR signaling molecules, was not signi®cantly dierent in cell lines from control tissues; (iv) in contrast, levels of IRS-1 protein, the major substrate for both IGF-I receptor and insulin receptor, were found to be at least several folds greater in mouse and human medulloblastoma cell lines when compared with corresponding normal mouse and human cerebellum ( Figure 3) ; ®nally, (v) both mouse and human medulloblastoma cell lines die in suspension cultures when the function of the IGF-IR was challenged by a dominant negative mutant of the IGF-IR (486/STOP), or by antisense oligonucleotides aimed against the IGF-IR mRNA. Certain dierences between mouse and human medulloblastoma cell lines emerged, particularly when human tumor cell were compared with the normal human cerebellum. It appears that the IGF-IR and IRS-1 protein levels are extremely low in human pediatric cerebellum (Figure 3b ). Therefore, in comparison to the low levels in the control human tissues, both IGF-IR and IRS-1 are apparently reactivated in all three human medulloblastoma cell lines examined. This is distinct from mouse medulloblastoma cell lines in which only IRS-1 protein is strongly increased, and the IGF-IR protein level is not signi®cantly dierent from normal cerebellar controls (compare Figure 3a and b). There is of course concern related to the control human materials used in this study. The sections of human cerebellar tissues were acquired between 13.5 ± 36 h post mortem. Thus the possibility exists that the proteins isolated from these sections were not well preserved. Microscopic examination of the sections, and the abundant presence of the PI3-K band (85 kD) detected in all protein samples, including normal human cerebellar tissues (Figure 3) , partially excludes this possibility. Additionally, blots containing proteins from normal human cerebellum were reprobed with other antibodies (anti-EGF-R, anti-SHC and anti-Grb-2), demonstrating in all cases the presence of the corresponding proteins in this human material (Figure 3c) .
The ®nding that IRS-1 protein is strongly upregulated in all medulloblastoma cell lines, in combination with the presence of the functional IGF-IR may have implications as to the pathways which control the growth of primitive neuroectodermal tumors. Additionally, low levels of IRS-1 protein in normal dierentiated cerebellar tissues may have also other implications. As previously reported, signaling from the activated IGF-IR can trigger cellular dierentiation but only in the absence of IRS-1 protein (Valentinis et al., 1999b) . Therefore the possibility exists that developmental down-regulation of IRS-1 protein may be partially responsible for IGF-I-mediated cerebellar dierentiation. Conversely, reactivation of IRS-1 expression in cells from the external granular layer (Kulik et al., 1997; Reiss et al., 2000) . Additionally, the IRS-1 protein has transforming properties but only when overexpressed in cells with a functional IGF-IR (Fei et al., 1995) . In addition, the IRS-1 protein has been found to co-precipitate with the SV40 T antigen. Simultaneous ectopic expression of both IRS-1 and SV40 T is able to sustain the transformed phenotype of the cell, even in the absence of the IGF-IR (Fei et al., 1995) . We have selected two mouse medulloblastoma cell lines (Bs-1b and Bs-1c) that are JCV T-antigen negative and two cell lines (BcB8 and BsB13) that are JCV T-antigen positive (Krynska et al., 2000) . When the cells were analysed in monolayer cultures their growth responses following IGF-I stimulation were similar ( Figure 5 ). Dierences began to emerge when the cells were analysed in anchorage-independent conditions. In suspension, Tpositive cell lines (BsB8 and BsB13) survived well in serum-free medium and proliferated following IGF-I stimulation (Figure 6a) . Conversely, T-negative cell lines (Bs-1b and Bs-1c) died in suspension when cultured in serum-free medium (Figure 6a ). The cell loss was completely prevented by IGF-I (Figure 6a ), or partially attenuated by 10% FBS (Figure 6b compare open bars). Finally, T-positive cells responded to a much greater degree than T-negative cells when stimulated solely with IGF-I. At present we can only speculate about the mechanism/s responsible for the dierences in cell behavior in anchorage-independence. Considering that both T-positive and T-negative cells have similar levels of the IGF-IR and P13-K proteins, and both grossly overexpress IRS-1 (Figure 3) , it is feasible that the IGF-IR signaling pathway and JCV Tantigen may cooperate by amplifying the signal towards transformation in this cellular system. There are several reports that support this notion: JCV Tantigen has high homology to SV40 large T-antigen (Gallia et al., 1998) ; both JCV T-antigen and SV40 Tantigen have transforming properties (Gallia et al., 1998) ; SV40 T-antigen is not able to transform cells in the absence of IGF-IR (Sell et al., 1993) ; cells expressing functional IGF-IR can be transformed either by ectopic expression of SV40 T-antigen or by IRS-1 overexpression (Fei et al., 1995) ; IRS-1 coprecipitates with the SV40 T-antigen (Fei et al., 1995) , and SV40 T-antigen enhances expression from the IGF-1 promoter (Porcu et al., 1994) . Whether similar interactions exist between the IGF-IR system and the JCV T-antigen, and whether these interaction/s contribute to the development and progression of medulloblastoma remains to be determined.
IGF-IR protein levels between 2610 4 to 4610 4 IGF-IR molecules per cell seem to be high enough (Reiss et al., 1998b) to transduce both proliferative and survival signals in medulloblastoma cell lines. Indeed, 15 min following IGF-I stimulation all medulloblastoma cell lines responded with auto-phosphorylation of the IGF-IR (Figures 2 and 4a) , and tyrosine phosphorylation of IRS-1 (Figure 4b ). There are, however, some dierences in the activation of signaling molecules between the medulloblastoma cell lines analysed. For instance, when IGF-IR was immunoprecipitated from TE-671 cells, a strong additional band of about 80 ± 85 kD was detected when blots were probed with an anti-phosphotyrosine antibody ( Figure  3a) . The presence of this additional phosphoprotein exclusively in TE-671 cells did not depend on IGF-I stimulation. In addition, this band was not detected when the same blots were re-probed with anti-IGF-IR (Figure 3a lower panel) or with anti-PI3-K (p85) antibodies (not shown), excluding the possibility of a continuous association between the IGF-IR and PI3-K in these cells. It is possible also that this unidenti®ed phosphoprotein is responsible for false positive immuno-staining of TE-671 cells in serum-free medium (Figure 2k ), since tyrosine phosphorylation of the IGF-IR is not detected in these cells cultured in serum-free medium (Figure 4a ). Another abnormality of IGF-IR signaling involves residual phosphorylation of IRS-1 (Figure 3b ) and Akt/PKB (Figure 3d ) repeatedly detected in TE-671 cells, but not in other medulloblastoma cell lines cultured in serum-free medium. This constitutive phosphorylation of the signaling molecules may be responsible for the ability of this cell line to grow without exogenous stimulation ( Figure 5) . One explanation may be that TE-671 cells are stimulated in an autocrine manner via production and secretion of IGF-I. Such a possibility has already been proposed for Daoy cells (Patti et al., 2000) . In our hands however, and in contrast to TE-671, Daoy cells still require exogenous IGF-I to proliferate ( Figure 5 ). It must be emphasized that although TE-671 were isolated from a biopsy fragment from a cerebellar medulloblastoma, and were classi®ed once as a medulloblastoma cell line, several later articles criticized this classi®cation (for instance: Stratton et al., 1989; Pappas et al., 1996) . Accordingly, TE-671 cells possess features that categorize them as rhabdomyosarcomas rather than medulloblastomas (Stratton et al., 1989) . This includes mutation within N-Ras gene (Fults et al., 1989) , expression of the muscle-type nicotinic acetylcholine receptor (Pappas et al., 1996) , and the presence of intermediate ®lament protein, desmin (Pappas et al., 1996) . Since our present data show a strong discrepancy in the pattern of IGF-IR activation between TE-671 cells, and other mouse and human medulloblastoma cell lines examined, this extends even further the dierent origin of TE-671 cells.
Strong evidence supporting the role of the IGF-IR system in growth and survival of medulloblastoma cell lines comes from experiments in which the IGF-IR was challenged either with antisense oligonucleotides against the IGF-IR mRNA, or with a dominant negative mutant of the IGF-IR, designated as 486/ STOP (Figure 6b ). The 486/STOP product has been shown in our previous work to compete with the IGF-IR function, inhibiting growth and survival of cancer cells in both in vitro and in vivo experiments (Reiss et al., 1998a; D'Ambrosio et al., 1996; Dunn et al., 1998) . Importantly, our results show that medulloblastoma cells die in suspension cultures when challenged with the AS oligonucleotides or with the 486/STOP product (Figure 6b ). It has been previously reported that dierent manipulations aimed against the IGF-IR function have a much more dramatic eect on cancer cells forced to grow in anchorage-independence than on cells growing in monolayer cultures . This may suggest the possibility of targeting the IGF-IR function when tumor cells in®ltrate adjacent tissues. In this stage medulloblastoma cells may be forced temporarily to grow and survive anchorageindependence, a condition in which anti-apoptotic function of the IGF-IR is critical . Importantly, these treatments could be less harmful to normal anchorage-dependent host brain cells.
In summary, the medulloblastoma cell lines examined express major components of the IGF-IR system and grossly overexpress IRS-1 protein. Within 15 min after IGF-I stimulation mouse and human cell lines phosphorylate the b subunit of the IGF-IR, IRS-I, Akt/PKB, and MAP kinases; respond with proliferation when stimulated solely with the IGF-I; and are strongly inhibited when challenged with a dominant negative mutant of the IGF-IR (486/STOP), or with antisense oligonucleotides against the IGF-IR mRNA. The signi®cance of the fact that the IGF-IR may contribute to the growth of medulloblastoma cells was validated by a positive staining of biopsies from medulloblastoma patients with an antibody that recognizes the phosphorylated (active) form of the IGF-IR.
Materials and methods
Clinical samples
A total of six human medulloblastoma samples were obtained from the pathology archives of the following institutions: MCP-Hahnemann University (Philadelphia, PA, USA), and St. Christopher's Hospital for Children (Philadelphia, PA, USA). Formalin-®xed, paran embedded surgical resections were histologically classi®ed according to the World Health Organization Classi®cation of Tumors in the Nervous System. Samples of frozen human cerebellum (N906, N989 and N1061) were kindly provided by Dr Mary Herman and Dr Joel E Kleinman from the Neuropathology Section-CBDB NIMH (Bethesda, MD, USA).
Cell lines
The cell lines used include D283 Med human cells (ATCC# HTB-185) that originate from peritoneal metastases from a boy with medulloblastoma; Daoy human cell line (ATCC# HTB-186) isolated from a posterior fossa tumor of a 4-yearold boy; TE-671 human cells (ATCC# CRL-8805) isolated from a biopsy of a cerebellar medulloblastoma; and four mouse cell lines (Bs-1b, Bs-1c, BsB8, BsB13) derived from cerebellar medulloblastomas that developed spontaneously in transgenic mice expressing the early genome of the archetype form of the JC virus (Krynska et al., 2000) . All mouse cell lines included are positive for the major neuronal markers. In addition, Bs-1b and Bs-1c cells are JCV T-antigen negative, and BsB8 and BsB13 are JCV T-antigen positive (Krynska et al., 2000) . R600 mouse embryo ®broblasts that express 3610 4 IGF-IR molecules per cell Reiss et al., 1998b) . These cells were stably transduced with a retroviral expression vector containing 486/STOP cDNA cloned in frame with the Flag tag. Expression of the fusion protein 486/STOP-Flag is under control of Drosophila heat shock promoter (HSP) that ensures ecient production of the 486/ STOP product at 398C. Control R 7 GR219 cells were transduced with an`empty' retroviral vector.
Growth in monolayer
All cell lines were cultured in Dulbecco's Modi®ed Eagle Medium (DMEM) (GIBCO ± BRL, Grand Island, NY, USA) containing 10% fetal bovine serum (FBS), at 378C in a 9.6% CO 2 atmosphere. To make cells quiescent, they were seeded at a density of 2.5610 3 /cm 2 in the presence of serum. After 24 h, the cells were washed with Hank's balanced salt solution (HBSS) and incubated in serum-free medium (SFM) [DMEM supplemented with 0.1% bovine serum albumin (SIGMA)]. The cells became quiescent after 48 h in SFM, which was renewed with fresh medium every 24 h. Growth response to IGF-I was tested by stimulating quiescent cells with IGF-I (GIBCO ± BRL, Grand Island, NY, USA) at 50 ng/ml.
Preparation of the 486/STOP conditioned medium
To prepare conditioned medium (CM) containing the 486/ STOP product, 70% con¯uent R 7 /486/HSP/Flag cells grown in DMEM plus 10% FBS and 1 mg/ml of Puromycin were washed three times with PBS, and cultured in serum-free medium at 398C for an additional 24 h. The CM was collected and aliquots frozen at 7808C. Control CM (C/CM) was prepared in the same way from the R 7 GR219 cells that contain the empty retroviral vector. Collected conditioned media were concentrated about 10-fold using Centriprep 50 centrifugal ®lters (Amicon, Bedford, MA, USA), analysed by Western blotting for the presence of the 486/STOP product and utilized to compete with the IGF-IR function by mixing one volume of the 486/CM with one volume of the culture medium (DMEM+10% FBS). Control cultures were treated the same way with the exception that 486/CM was replaced with the C/CM.
Cell growth and survival in suspension
To determine this parameter, quiescent cells were detached from a culture dish with 0.02% EDTA (disodium ethylenediamine tetraacetate), and seeded on dishes coated with poly(2-hydroxyethyle methacrylate) [poly(HEMA)] (Aldrich, Milwaukee, WI, USA), prepared according to the methodology previously described (Reiss et al., 1998b) . Cells were seeded in 10% FBS at concentration of 1610 5 cells/35 mm dish, and were treated either with 5 mM antisense oligonucleo-tides (Reiss et al., 1995) , or with the 486/CM, or were left untreated. Forty-eight hours later cell suspensions were collected, dissociated with 0.25% trypsin, and cells were counted in a Bright-line Hemocytometer. Results represent an average of three experiments, and are expressed as per cent increase or decrease in cell number over time zero (T0). Sequences of phosphorothioate antisense (AS) and mismatched (MM) oligonucleotides to the IGF-IR mRNA were previously described (Reiss et al., 1995) .
Western blots and immuno-precipitation
To determine total IGF-IR, IRS-1 and PI3-K levels, monolayer cultures or small fragments of cerebellar tissue were lysed on ice with 400 ml of lysis buer [(50 mM HEPES); pH 7.5; 150 mM NaCl; 1.5 mM MgCl 2 ; 1 mM EGTA; 10% glycerol; 1% Triton X-100; 1 mM phenylmethylsulfonyl uoride (PMSF); 0.2 mM Na-orthovanadate and 10 mg/ml aprotinin]. Protein concentration was determined by a BioRad Protein Assay (BioRad, Hercules, CA, USA), and 50 mg of total proteins separated on a 4 ± 15% gradient SDS ± PAGE (BioRad) and transferred into nitrocellulose membranes. Blots were blocked with 5% non-fat dry milk in TBST (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Tween 20), probed with rabbit anti-IGF-IRb antibody (Santa Cruz Inc. Santa Cruz, CA, USA); rabbit anti-IRS-1 antibody (Upstate Biotechnology Inc., Lake Placid, NY, USA), rabbit anti-PI3-K (p85) antibody (Upstate Biotechnology), and with anti-rabbit-HRP conjugated secondary antibody (Calbiochem, San Diego, CA, USA). Blots were developed with ECL detection reagents (Amersham, Arlington, IL, USA). To determine phosphorylated forms of IGF-IR, IRS-1, Akt/PKB and MAP kinases, quiescent cells were stimulated with IGF-I (50 ng/ml) and total proteins were extracted 15 min after stimulation. Total and phosphorylated Akt/PKB levels were determined by PhosphoPlus Akt(Ser473) antibody kit (New England BioLabs, Beverly, MA, USA), and total and phosphorylated ERKs levels were determined by PhosphoPlus Phospho-p44/42 MAP kinase (Thr202/Tyr204) antibody kit (New England BioLabs, Beverly, MA, USA). To determine IGF-IR tyrosine phosphorylation IGF-IR was immuno-precipitated from 500 mg protein extracts with mouse anti-IGF-IR antibody (Calbiochem, San Diego, CA, USA) and agarose conjugated anti-mouse IgG (Sigma, St. Louis, MO, USA), and corresponding blots developed ®rst with anti-phosphotyrosine (PY) antibody (Transduction Laboratories, Lexington, KY, USA) (PY20: HRP), and reprobed with anti-IGF-IR antibody (Santa Cruz). To determine IRS-1 tyrosine phosphorylation IRS-1 was immuno-precipitated from 500 mg protein extracts with rabbit anti-IRS-1 antibody (Transduction Laboratories) and agarose conjugated protein A (Calbiochem). Corresponding blots were developed ®rst with anti-phosphotyrosine (PY20) antibody, and re-probed with N-terminal anti-IRS-1 antibody (Santa Cruz).
Immunohistochemistry
Formalin ®xed, paran embedded samples were sectioned at 4 microns thickness and stained with Hematoxylin-Eosin for routine histological analysis. Immunohistochemistry was performed by using the avidin-biotin-peroxidase complex system, according to the manufacturer's instructions (Vectastain Elite ABC Peroxidase Kit; Vector Laboratories). Brie¯y, sections were deparanized in xylene and re-hydrated through alcohols up to water. Sections were heated in 0.01 M sodium citrate buer (pH 6.0) to 958C under vacuum for 40 min and allowed to cool for 20 min at room temperature for non-enzymatic antigen retrieval. The slides were rinsed with PBS and incubated in MeOH/3% H 2 O 2 for 20 min to quench endogenous peroxidase. Sections were then washed with PBS and blocked in PBS/0.1% BSA containing 5% normal horse or goat serum for 2 h at room temperature, and incubated overnight at room temperature with primary antibodies. The primary antibodies utilized were rabbit antipY1316 IGF-IR (1 : 500 dilution); rabbit anti-IGF-IR (1 : 500 dilution, Santa Cruz); anti-GFAP antibody (1 : 100 dilution, DACO); anti-neuro®laments antibody (1 : 500 dilution, Sternberger Monoclonals); and anti-synaptophysin antibody (1 : 500 dilution, clone SY38; Roche Molecular, Indianapolis, IN, USA). Secondary antibodies used were biotin-conjugated anti-mouse and anti-rabbit IgGs (Vector). Following secondary antibodies, avidin-biotin peroxidase complexes (Vector) were incubated for 1 h at room temperature, sections were developed with diaminobenzidine substrate (Sigma), counterstained with hematoxylin and mounted with Permont. For immunocytochemistry, cells cultured on poly-D-lysine coated glass chamber slides (Nunc) were washed in cold PBS, ®xed with cold acetone and stained as described for immunohistochemistry.
